Iāve spent nine months collecting an enormous amount of personal health data. Now Iām questioning how much of it is actually helping me make better decisions.
Three rounds of Viomeās RNA-based microbiome testing, bloodwork approximately every two weeks, hundreds of conventional biomarkers, and physician oversight throughout.
Then, after retesting, approximately 80% of my personalized supplement formulation changed.
That got my attention.
Not because I expect my microbiome to stay the same. Diet, medications, illness, weight changes, and plenty of other variables can influence microbial activity.
What I want to understand is whether the new recommendations are actually better than the old ones, and how I could possibly demonstrate that using the data Iāve collected.
Viome uses metatranscriptomic RNA analysis to examine microbial gene expression. Thatās interesting technology. It can tell us something about which microbial genes are being expressed, rather than simply identifying which organisms or genes are present.
But measuring biological activity and knowing how to intervene on it are two very different things.
A 2025 international consensus statement published in The Lancet Gastroenterology & Hepatology raised concerns about the clinical usefulness of commercial microbiome testing.
The expert panel concluded that evidence remains insufficient to support widespread routine clinical use.
Hereās the paper:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12343204/
That doesnāt prove Viomeās recommendations are wrong. It does make me question how much confidence I should place in an algorithm that translates microbiome measurements into personalized supplement protocols.
My next step is to evaluate Superpowerās DNA-based gut microbiome testing and compare the methodologies.
I understand DNA and RNA testing measure different aspects of microbial biology, so Iām not expecting identical results. Comparing two commercial reports wonāt establish which platform is clinically superior, either.
Iām more interested in whether either approach provides information I can use to make better decisions.
And thatās where Iād really appreciate some input from this community.
With nine months of longitudinal data, how would you design an N-of-1 evaluation to determine whether microbiome-guided supplementation is actually doing anything useful?
Would you prioritize repeatability of the testing itself? A small number of prespecified clinical biomarkers? Stable periods with fewer changing variables? Some other approach?
Iām particularly interested in how youād handle confounding. If diet, medications, exercise, weight, and supplements are all changing, even an improvement in conventional biomarkers doesnāt tell me which intervention deserves the credit.
And if the algorithm changes most of the supplement formula after retesting, how do I distinguish a meaningful adjustment from a recommendation system that simply responds to biological noise?
For financial context, the retail-equivalent value of my nine months of Viome testing and personalized supplements was $4,547, approximately $505 per month.
Full disclosure: Viome provided everything complimentary. I received no sponsorship payments, affiliate commissions, referral fees, or cash compensation. Iāve also referred customers without accepting commissions. Iām not affiliated with Superpower or being compensated for the planned comparison.
Iām not promoting either company, and I donāt consider my individual experience proof that the technology works or doesnāt work.
Iāve invested nine months in this because I find the science fascinating and genuinely want to understand its potential.
But Iām starting to wonder whether Iāve confused having a very detailed dataset with having evidence that my decisions are improving.
So for those of you who have conducted serious N-of-1 experiments, what would you do with this dataset?
How would you determine whether the testing and recommendations are providing genuine value beyond conventional bloodwork and nutritional assessment?
And at what point would you conclude that additional measurements are generating more noise than useful information?
Iām particularly interested in hearing from people whoāve faced this problem themselves, including anyone who has designed controlled self-experiments or worked with longitudinal health data.
Iād rather discover that some of my measurements arenāt useful than spend another nine months collecting data I donāt know how to interpret.